| Year |
Citation |
Score |
| 2014 |
Tomaszewski JJ, Richman EL, Sadetsky N, O'Keefe DS, Carroll PR, Davies BJ, Chan JM. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. The Journal of Urology. 191: 971-6. PMID 24095905 DOI: 10.1016/J.Juro.2013.09.065 |
0.632 |
|
| 2013 |
Sonn GA, Sadetsky N, Presti JC, Litwin MS. Differing perceptions of quality of life in patients with prostate cancer and their doctors. The Journal of Urology. 189: S59-65; discussion S. PMID 23234635 DOI: 10.1016/J.Juro.2012.11.032 |
0.482 |
|
| 2012 |
Wu AK, Reese AC, Cooperberg MR, Sadetsky N, Shinohara K. Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer Prostate Cancer and Prostatic Diseases. 15: 100-105. PMID 22042252 DOI: 10.1038/Pcan.2011.52 |
0.642 |
|
| 2012 |
Punnen S, Cooperberg MR, Sadetsky N, Carroll PR. Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores? Bju International. 109: 1520-4. PMID 21999368 DOI: 10.1111/J.1464-410X.2011.10605.X |
0.405 |
|
| 2011 |
Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, et al. Prediction of erectile function following treatment for prostate cancer. Jama. 306: 1205-14. PMID 21934053 DOI: 10.1001/Jama.2011.1333 |
0.536 |
|
| 2011 |
Punnen S, Cooperberg MR, Sadetsky N, Carroll PR. Androgen deprivation therapy and cardiovascular risk. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3510-6. PMID 21844498 DOI: 10.1200/Jco.2011.35.1494 |
0.456 |
|
| 2011 |
Sadetsky N, Greene K, Cooperberg MR, Hubbard A, Carroll PR, Satariano W. Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry. Cancer. 117: 4406-13. PMID 21412760 DOI: 10.1002/Cncr.26064 |
0.748 |
|
| 2011 |
Chamie K, Sadetsky N, Litwin MS. Physician assessment of pretreatment functional status: a process-outcomes link. The Journal of Urology. 185: 1229-33. PMID 21334026 DOI: 10.1016/J.Juro.2010.11.087 |
0.605 |
|
| 2011 |
Reese AC, Sadetsky N, Carroll PR, Cooperberg MR. Inaccuracies in assignment of clinical stage for localized prostate cancer. Cancer. 117: 283-9. PMID 21210472 DOI: 10.1002/Cncr.25596 |
0.527 |
|
| 2011 |
Wilson L, Basu R, Paoli C, Lian V, Wong A, Kuo J, Sadetsky N, Cooperberg M, Carroll P. PCN11 COMPARATIVE EFFECTIVENESS RESEARCH: ERECTILE DYSFUNCTION LONGITUDINAL COSTS ACROSS TREATMENTS FOR PROSTATE CANCER Value in Health. 14: A156. DOI: 10.1016/J.Jval.2011.02.869 |
0.574 |
|
| 2011 |
Punnen S, Cooperberg M, Sadetsky N, Fuldeore M, Carroll P. 721 Causes Of Mortality Following Treatment For Prostate Cancer: What Is The Impact Of Androgen Deprivation? The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1689 |
0.535 |
|
| 2011 |
Alemozaffar M, Sanda M, Sadetsky N, Regan M, Carroll P, Cooperberg M. 1535 Personalized Prediction Of Erection Recovery After Primary Prostate Cancer Treatment: Validation In The Community-Based Capsure Cohort Of A Predictive Model Developed In Prostqa The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1530 |
0.496 |
|
| 2010 |
Daskivich TJ, van de Poll-Franse LV, Kwan L, Sadetsky N, Stein DM, Litwin MS. From bad to worse: comorbidity severity and quality of life after treatment for early-stage prostate cancer. Prostate Cancer and Prostatic Diseases. 13: 320-7. PMID 20838413 DOI: 10.1038/Pcan.2010.33 |
0.57 |
|
| 2010 |
Daskivich T, Sadetsky N, Kaplan SH, Greenfield S, Litwin MS. Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Archives of Internal Medicine. 170: 1396-7. PMID 20696968 DOI: 10.1001/Archinternmed.2010.251 |
0.624 |
|
| 2010 |
Huang GJ, Sadetsky N, Penson DF. Health related quality of life for men treated for localized prostate cancer with long-term followup. The Journal of Urology. 183: 2206-12. PMID 20399462 DOI: 10.1016/J.Juro.2010.02.013 |
0.538 |
|
| 2010 |
Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll PR. Changes in specific domains of sexual function and sexual bother after radical prostatectomy. Bju International. 106: 1022-9. PMID 20184571 DOI: 10.1111/J.1464-410X.2010.09231.X |
0.492 |
|
| 2010 |
Daskivich TJ, Sadetsky N, Kaplan SH, Greenfield S, Litwin MS. Comorbidity severity and long-term mortality in men with early-stage prostate cancer. Journal of Clinical Oncology. 28: 6005-6005. DOI: 10.1200/Jco.2010.28.15_Suppl.6005 |
0.649 |
|
| 2010 |
Sadetsky N, Cooperberg M, Braithwaite D, Pasick R. Abstract B86: Health care utilization during transition to Medicare coverage in patients with prostate cancer: Evidence from CaPSURE registry Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-B86 |
0.577 |
|
| 2009 |
Sonn GA, Sadetsky N, Presti JC, Litwin MS. Differing perceptions of quality of life in patients with prostate cancer and their doctors. The Journal of Urology. 182: 2296-302. PMID 19758610 DOI: 10.1016/j.juro.2009.07.027 |
0.519 |
|
| 2009 |
Sadetsky N, Hubbard A, Carroll PR, Satariano W. Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 18: 1019-27. PMID 19697155 DOI: 10.1007/S11136-009-9526-7 |
0.714 |
|
| 2009 |
Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll PR. The impact of obesity on overall and cancer specific survival in men with prostate cancer. The Journal of Urology. 182: 112-7; discussion 11. PMID 19447437 DOI: 10.1016/J.Juro.2009.02.118 |
0.523 |
|
| 2009 |
Chen RC, Sadetsky N, Chen MH, Carroll PR, D'Amico AV. Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy. International Journal of Radiation Oncology, Biology, Physics. 75: 36-9. PMID 19233568 DOI: 10.1016/J.Ijrobp.2008.10.059 |
0.637 |
|
| 2009 |
Tollefson MK, Sadetsky N, Blute ML, Greene KL, Carroll PR. Determinants Of Quality Of Life Among Prostate Cancer Survivors Treated By Community Practices The Journal of Urology. 181: 209-209. DOI: 10.1016/S0022-5347(09)60601-7 |
0.563 |
|
| 2008 |
Wu AK, Cooperberg MR, Sadetsky N, Carroll PR. Health related quality of life in patients treated with multimodal therapy for prostate cancer. The Journal of Urology. 180: 2415-22; discussion . PMID 18930279 DOI: 10.1016/J.Juro.2008.08.015 |
0.54 |
|
| 2008 |
White WM, Sadetsky N, Waters WB, Carroll PR, Litwin MS. Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database. The Journal of Urology. 180: 2409-13; discussion . PMID 18930270 DOI: 10.1016/J.Juro.2008.08.079 |
0.536 |
|
| 2008 |
van de Poll-Franse LV, Sadetsky N, Kwan L, Litwin MS. Severity of cardiovascular disease and health-related quality of life in men with prostate cancer: a longitudinal analysis from CaPSURE. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 17: 845-55. PMID 18506598 DOI: 10.1007/S11136-008-9356-Z |
0.601 |
|
| 2008 |
Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR. Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database. Urologic Oncology. 26: 271-5. PMID 18452818 DOI: 10.1016/J.Urolonc.2007.04.006 |
0.513 |
|
| 2008 |
Sadetsky N, Lubeck DP, Pasta DJ, Latini DM, DuChane J, Carroll PR. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor. Bju International. 101: 691-7. PMID 18291018 DOI: 10.1111/J.1464-410X.2007.07353.X |
0.637 |
|
| 2008 |
Davies BJ, Walsh TJ, Ross PL, Knight SJ, Sadetsky N, Carroll PR, Kane CJ. Effect of BMI on primary treatment of prostate cancer. Urology. 72: 406-11. PMID 18267336 DOI: 10.1016/J.Urology.2007.11.032 |
0.576 |
|
| 2008 |
Lee IH, Sadetsky N, Carroll PR, Sandler HM. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors. The Journal of Urology. 179: 1072-6; discussion 1. PMID 18206926 DOI: 10.1016/J.Juro.2007.10.053 |
0.569 |
|
| 2008 |
Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 112: 307-14. PMID 18050294 DOI: 10.1002/Cncr.23161 |
0.575 |
|
| 2008 |
Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR. Prostate cancer outcomes among older men: Insurance status comparisons results from CaPSURE database Prostate Cancer and Prostatic Diseases. 11: 280-287. PMID 17893700 DOI: 10.1038/Sj.Pcan.4501015 |
0.615 |
|
| 2008 |
Wilson L, Liang S, Kwon P, Tesoro R, Sadetsky N, Greene K, Broering J, Carroll P. Pcn48 Longitudinal Comparison Across Treatments, Risk And Age Of Work Loss Costs In Prostate Cancer Patients: 10 Year Patterns Value in Health. 11. DOI: 10.1016/S1098-3015(10)70226-6 |
0.537 |
|
| 2008 |
Dall'Era MA, Konety BR, Sadetsky N, Carroll PR. The Association Between Insurance Status And Prostate Cancer Risk Category At Presentation The Journal of Urology. 179: 207-207. DOI: 10.1016/S0022-5347(08)60598-4 |
0.595 |
|
| 2008 |
White WM, Sadetsky N, Waters WB, Carroll PR, Litwin MS. Quality Of Life Among Men With Locally Advanced Adenocarcinoma Of The Prostate The Journal of Urology. 179: 162-163. DOI: 10.1016/S0022-5347(08)60469-3 |
0.567 |
|
| 2007 |
Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. Journal of the National Cancer Institute. 99: 1516-24. PMID 17925537 DOI: 10.1093/Jnci/Djm168 |
0.541 |
|
| 2007 |
Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database. Urology. 70: 106-10. PMID 17656218 DOI: 10.1016/J.Urology.2007.03.018 |
0.614 |
|
| 2007 |
Konety BR, Sadetsky N, Carroll PR. Recovery of urinary continence following radical prostatectomy: the impact of prostate volume--analysis of data from the CaPSURE Database. The Journal of Urology. 177: 1423-5; discussion 1. PMID 17382745 DOI: 10.1016/J.Juro.2006.11.089 |
0.6 |
|
| 2007 |
Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane CJ, DuChane J, Carroll PR. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Cancer. 109: 1769-76. PMID 17380491 DOI: 10.1002/Cncr.22597 |
0.518 |
|
| 2007 |
Berglund RK, Sadetsky N, DuChane J, Carroll PR, Klein EA. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE. The Journal of Urology. 177: 526-29; discussion 5. PMID 17222625 DOI: 10.1016/J.Juro.2006.09.053 |
0.41 |
|
| 2007 |
Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR. Cumulative cost pattern comparison of prostate cancer treatments. Cancer. 109: 518-27. PMID 17186528 DOI: 10.1002/Cncr.22433 |
0.515 |
|
| 2007 |
Arredondo SA, Latini DM, Sadetsky N, Kawakami J, Pasta DJ, DuChane J, Carroll PR. Quality of life for men receiving a second treatment for prostate cancer. The Journal of Urology. 177: 273-8; discussion 27. PMID 17162062 DOI: 10.1016/J.Juro.2006.08.061 |
0.526 |
|
| 2007 |
Sadetsky N, Latini D, Carroll P. Pcn56 Relationship Between Functional Status And Self Rated Health In Patients With Prostate Cancer: Data From Capsure Value in Health. 10. DOI: 10.1016/S1098-3015(10)68966-8 |
0.535 |
|
| 2007 |
Lee IH, Sadetsky N, Carroll PR, Sandler HM. 1044: Response to PDE5-I for Erectile Dysfunction (ED) Following Surgery or Radiation Therapy for Prostate Cancer: A Capsure Study The Journal of Urology. 177: 345-346. DOI: 10.1016/S0022-5347(18)31272-2 |
0.523 |
|
| 2007 |
Tsai HK, D'Amico AV, Sadetsky N, Chen M, Carroll PR. 378: Androgen Deprivation Therapy for Prostate Cancer and the Risk of Cardiac Mortality The Journal of Urology. 177: 125-126. DOI: 10.1016/S0022-5347(18)30631-1 |
0.554 |
|
| 2007 |
Huang GJ, Sadetsky N, Carroll PR, Penson DF. 8: Predictors of HRQOL Duirng Long-Term Follow-Up of Men Treated for Prostate Cancer The Journal of Urology. 177: 3-4. DOI: 10.1016/S0022-5347(18)30273-8 |
0.609 |
|
| 2006 |
Kawakami J, Meng MV, Sadetsky N, Latini DM, Duchane J, Carroll PR. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. The Journal of Urology. 176: 1382-6. PMID 16952638 DOI: 10.1016/J.Juro.2006.06.001 |
0.57 |
|
| 2006 |
Latini DM, Elkin EP, Cooperberg MR, Sadetsky N, Duchane J, Carroll PR. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE. Cancer. 106: 789-95. PMID 16400651 DOI: 10.1002/Cncr.21675 |
0.566 |
|
| 2006 |
MacDonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Bakst AW, Carroll PR. Predicting men at high risk for PSA failure after salvage radiotherapy for rising PSA following prostatectomy Journal of Clinical Oncology. 24: 4570-4570. DOI: 10.1200/Jco.2006.24.18_Suppl.4570 |
0.474 |
|
| 2006 |
Sadetsky N, Greene K, DuChane J, Carroll PR. Is insurance Status associated with Survival in Prostate Cancer Patients? Data from Capsuret American Journal of Epidemiology. 163. DOI: 10.1093/Aje/163.Suppl_11.S113-D |
0.607 |
|
| 2006 |
Sadetsky N, Elkin E, Carroll P. Pcn42 Predictive Value Of Serial Measurements Of Quality Of Life On All-Cause Mortality In Prostate Cancer Patients: Data From Capsure™ Value in Health. 9. DOI: 10.1016/S1098-3015(10)64666-9 |
0.554 |
|
| 2006 |
Berglund RK, Sadetsky N, Duchane J, Carroll PR, Klein EA. 1594: Limited Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy does Not Affect Five-Year Biochemical Failure Rates for Low-, Intermediate-, and High-Risk Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Oat Abase The Journal of Urology. 175: 513-514. DOI: 10.1016/S0022-5347(18)33786-8 |
0.583 |
|
| 2006 |
Kane CJ, Ross PL, Sadetsky N, Elkin EP, Chan JM, Duchane J, Carroll PR. 1577: The Effect of Obesity on Prostate Cancer Treatment; Results from Capsure The Journal of Urology. 175: 508-508. DOI: 10.1016/S0022-5347(18)33769-8 |
0.561 |
|
| 2006 |
Meng MV, Sadetsky N, Latini DM, Duchane J, Chan JM, Carroll PR. 1507: Body Mass Index, Prostate Size, and Prostate Specific Antigen in Men with Prostate Cancer The Journal of Urology. 175: 486-487. DOI: 10.1016/S0022-5347(18)33711-X |
0.608 |
|
| 2006 |
MacDonald OK, D’Amico AV, Sadetsky N, Shrieve DC, Duchane J, Carroll PR. 1189: Clinical Risk Group Predicts for PSA Recurrence Following Radical Prostatectomy and Adjuvant Radiotherapy: From the Capsuretm Database The Journal of Urology. 175: 382-383. DOI: 10.1016/S0022-5347(18)33414-1 |
0.379 |
|
| 2006 |
Konety BR, Sadetsky N, Duchane J, Carroll PR. 678: Recovery of Urinary Continence Following Radical Prostatectomy: The Impact of Prostate Volume The Journal of Urology. 175: 219-219. DOI: 10.1016/S0022-5347(18)32924-0 |
0.55 |
|
| 2006 |
Ross PL, Sadetsky N, Duchane J, Carroll PR, Kane CJ. 481: The Impact of Obesity on Secondary Treatment, Overall Survival, and Disease-Specific Survival in Men with Prostate Cancer: Results from Capsure The Journal of Urology. 175: 156-156. DOI: 10.1016/S0022-5347(18)32737-X |
0.56 |
|
| 2006 |
Meng MV, Sadetsky N, Latini DM, Duchane J, Carroll PR. 137: Competing Causes of Death in Men with Prostate Cancer: Data from Capsure The Journal of Urology. 175: 44-44. DOI: 10.1016/S0022-5347(18)32404-2 |
0.61 |
|
| 2005 |
Greene KL, Elkin EP, Wilson L, Sadetsky N, Broering JM, Duchane J, Latini DM, Carroll PR. Long-term health care resource utilization in men with localized prostate cancer treated with radical prostatectomy: Data from CaPSURE. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6078. PMID 27945928 DOI: 10.1200/Jco.2005.23.16_Suppl.6078 |
0.623 |
|
| 2005 |
Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology. 66: 1060-5. PMID 16286124 DOI: 10.1016/J.Urology.2005.05.040 |
0.577 |
|
| 2005 |
Sadetsky N, Lubeck DP, Latini DM, Pasta DJ, Kawakami J, DuChane J, Carroll PR. Demographics, insurance coverage, and utilization of medical services in newly diagnosed prostate cancer: data from caPSURE. Managed Care Interface. 18: 25-30. PMID 15766061 |
0.435 |
|
| 2005 |
Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan JM, Cooperberg MR, Carroll PR, Kane CJ. The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). The Journal of Urology. 173: 1132-8. PMID 15758721 DOI: 10.1097/01.Ju.0000154973.38301.7F |
0.513 |
|
| 2005 |
Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. The Journal of Urology. 173: 732-6. PMID 15711258 DOI: 10.1097/01.Ju.0000152408.25738.23 |
0.475 |
|
| 2005 |
Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR. 192: Prostate Cancer Treatment and Insurance Status: Data from Capsure™ The Journal of Urology. 173: 52-53. DOI: 10.1016/S0022-5347(18)34457-4 |
0.624 |
|
| 2004 |
Litwin MS, Sadetsky N, Pasta DJ, Lubeck DP. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE. The Journal of Urology. 172: 515-9. PMID 15247718 DOI: 10.1097/01.Ju.0000129236.56712.E7 |
0.641 |
|
| 2004 |
Mehta SS, Lubeck DP, Sadetsky N, Pasta DJ, Carroll PR. Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE. The Journal of Urology. 171: 215-9. PMID 14665879 DOI: 10.1097/01.Ju.0000100087.83112.23 |
0.604 |
|
| 2004 |
Sadetsky N, Kneier A, Latini D, Knight S, Loi J, Carroll P. Pcn21 Short-Term Psychosocial Counseling For Patients With Newly-Diagnosed Prostate Cancer Value in Health. 7: 252. DOI: 10.1016/S1098-3015(10)62163-8 |
0.592 |
|
| 2004 |
Latini DM, Elkin EP, Cooperberg MR, Sadetsky N, Wallace KL, Carroll PR. 467: Differences in Clinical Characteristics and Disease-Free Survival for Latino, African-American, and Non-Latino White Men with Prostate Cancer: Data from Capsure™ The Journal of Urology. 171: 124-125. DOI: 10.1016/S0022-5347(18)37729-2 |
0.558 |
|
| 2004 |
Kane CJ, Bassett WW, Sadetsky N, Silva SJ, Pasta DJ, Cooperberg MR, Chan JM, Wallace KL, Carroll PR. 464: Is Obesity Associated with more Aggressive Prostate Cancer? (Data from Capsure) The Journal of Urology. 171: 124-124. DOI: 10.1016/S0022-5347(18)37726-7 |
0.553 |
|
| 2003 |
Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE. The Journal of Urology. 170: 1822-7. PMID 14532784 DOI: 10.1097/01.Ju.0000091426.55735.F0 |
0.639 |
|
| 2003 |
Mehta S, Lubeck D, Sadetsky N, Pasta D, Carroll P. Pchi: Second Treatment Patterns In Prostate Cancer Patients With Biochemical Failure: Data From Capsure Value in Health. 6: 227-228. DOI: 10.1016/S1098-3015(10)63921-6 |
0.585 |
|
| 2002 |
Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology. 60: 7-11; discussion 11-. PMID 12231037 DOI: 10.1016/S0090-4295(02)01560-1 |
0.637 |
|
| Show low-probability matches. |